Latest News: Proscia Receives FDA 510(k) Clearance For Concentriq AP-DxREAD THE PRESS RELEASE

Conversation with Julianna Ianni, Vice President of Artificial Intelligence Research and Development at Proscia

By Author Proscia | March 14, 2023

Julianna Ianni, Ph.D., VP of AI Research and Development, sat down with Pathology News for an in-depth interview. Read on to hear about her team’s recent research, the growing impact of AI-powered process automation applications like our Automated Quality Control, and how she’s seen pathologists’ views of computational pathology change over the past few years.

Our website uses cookies. By using this site, you agree to its use of cookies.